Dea S Stenbaek
Overview
Explore the profile of Dea S Stenbaek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larsen K, Lindberg U, Ozenne B, McCulloch D, Armand S, Madsen M, et al.
J Cereb Blood Flow Metab
. 2025 Feb;
:271678X251323364.
PMID: 40007438
Psilocin, the active metabolite of psilocybin, is a psychedelic and agonist at the serotonin 2A receptor (5-HT2AR) that has shown positive therapeutic effects for brain disorders such as depression. To...
2.
Jensen K, Dam V, Kohler-Forsberg K, Ozenne B, Stenbaek D, Ganz M, et al.
J Psychiatr Res
. 2024 Dec;
181():197-205.
PMID: 39616866
Serotonin reuptake inhibitors have been reported to increase hippocampal volume and improve memory function in patients with Major depressive disorder (MDD). The postsynaptic 5-HT4 receptor (5-HT4R) is involved in hippocampal...
3.
Dam V, Kohler-Forsberg K, Ozenne B, Larsen S, Ip C, Jorgensen A, et al.
Biol Psychiatry
. 2024 Aug;
97(3):261-268.
PMID: 39181386
Background: Brain serotonin 4 receptor (5-HTR) levels are lower in untreated patients with major depressive disorder (MDD) and are linked to verbal memory. Here, we investigated the relationship between 5-HTR...
4.
Holze F, Madsen M, Svarer C, Gillings N, Stenbaek D, Rudin D, et al.
Eur Neuropsychopharmacol
. 2024 Aug;
88:43-48.
PMID: 39121715
The serotonin 2A (5-HT2A) receptor is an important target for drug development and the main receptor through which classical psychedelics elucidate their hallucinogenic effects. The 5-HT2A receptor antagonist ketanserin has...
5.
Segerberg T, Ozenne B, Dam V, Kohler-Forsberg K, Jorgensen M, Frokjaer V, et al.
J Affect Disord
. 2024 May;
360:322-325.
PMID: 38810785
Background: Rumination is a maladaptive response to distress characteristic of Major Depressive Disorder (MDD). It is unclear to what degree rumination is associated with depression severity prior to treatment and...
6.
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity
Madsen M, Petersen A, Stenbaek D, Sorensen I, Schionning H, Fjeld T, et al.
Headache
. 2024 Jan;
64(1):55-67.
PMID: 38238974
Objective: To evaluate the feasibility and prophylactic effect of psilocybin as well as its effects on hypothalamic functional connectivity (FC) in patients with chronic cluster headache (CCH). Background: CCH is...
7.
Johansen A, Armand S, Plaven-Sigray P, Nasser A, Ozenne B, Petersen I, et al.
Mol Psychiatry
. 2023 Oct;
28(10):4272-4279.
PMID: 37814129
Selective serotonin reuptake inhibitors (SSRIs) are widely used for treating neuropsychiatric disorders. However, the exact mechanism of action and why effects can take several weeks to manifest is not clear....
8.
Armand S, Wagner M, Ozenne B, Verbunt J, Sep S, Berg S, et al.
J Cardiovasc Nurs
. 2023 Sep;
37(4):394-401.
PMID: 37707973
Background: Posttraumatic stress disorder (PTSD) is prevalent in patients who have had a cardiac arrest and their partners. Accordingly, acute traumatic stress screening is recommended, but its association with later...
9.
Kohler-Forsberg K, Dam V, Ozenne B, Sankar A, Beliveau V, Landman E, et al.
JAMA Psychiatry
. 2023 Feb;
80(4):296-304.
PMID: 36753296
Importance: The cerebral serotonin 4 (5-HT4) receptor is a promising novel target for treatment of major depressive disorder (MDD), and pharmacological stimulation of the 5-HT4 receptor has been associated with...
10.
Langley C, Armand S, Luo Q, Savulich G, Segerberg T, Sondergaard A, et al.
Neuropsychopharmacology
. 2023 Jan;
48(4):664-670.
PMID: 36683090
Several studies of the effects on cognition of selective serotonin reuptake inhibitors (SSRI), administered either acutely or sub-chronically in healthy volunteers, have found changes in learning and reinforcement outcomes. In...